Efficacy and Safety of Chinese Medicine JCM-16021 for Diarrhea-predominant Irritable Bowel Syndrome
Condition:   Irritable Bowel Syndrome Interventions:   Drug: JCM-16021;   Drug: Placebo Sponsors:   ZhaoXiang Bian;   Chinese University of Hong Kong Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 7, 2018 Category: Research Source Type: clinical trials

SMART Program in Irritable Bowel Syndrome (IBS)
Condition:   Irritable Bowel Syndrome Intervention:   Behavioral: Stress Management and Resilience Training Program Sponsor:   University of California, Los Angeles Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 5, 2018 Category: Research Source Type: clinical trials

L. Casei DG ® in Patients With Irritable Bowel Syndrome.
Condition:   IBS - Irritable Bowel Syndrome Interventions:   Dietary Supplement: L.casei DG;   Dietary Supplement: PLACEBO Sponsors:   SOFAR S.p.A.;   1Med Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 28, 2018 Category: Research Source Type: clinical trials

Individual vs. Group Hypnotherapy in Patients With Irritable Bowel Syndrome
Condition:   IBS - Irritable Bowel Syndrome Intervention:   Other: Hypnotherapy Sponsor:   Sahlgrenska University Hospital, Sweden Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 13, 2018 Category: Research Source Type: clinical trials